Showing 1 posts of 1 posts found.
Biotech development firm immatics has announced the appointment of Peter Chambré as chairman of the Board. Chambré has had extensive …
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
Acumentis CEO Herspiegel steps down as Burden assumes role
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
Hot-tub therapy tested as potential treatment for peripheral artery disease
Raimond takes helm at Nuclera